Answer
It is preferable to avoid Kyntheum (brodalumab) during pregnancy as a precaution because pregnancy data are absent or limited and brodalumab has the potential to reach the developing foetus.
Sources for this answer
- Kyntheum 210 mg Solution for InjectionLeo Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked